Sox17 as a candidate regulator of myeloid restricted differentiation potential

Development Growth and Differentiation

Volumn 56, Issue 6, 2014, Pages 469-479

  Anani, Maha ^a,b   Nobuhisa, Ikuo ^a   Osawa, Mitsujiro ^c,d   Iwama, Atsushi ^c,e   Harada, Kaho ^a   Saito, Kiyoka ^a   Taga, Tetsuya ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Suez Canal University Faculty of Medicine   (Egypt)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Aorta gonad mesonephros; Common myeloid progenitors; Granulocyte macrophage progenitors; Self renewal; Sry related high mobility group box 17

Indexed keywords

C MPL PROTEIN; CD34 ANTIBODY; CELL SURFACE RECEPTOR; ERYTHROPOIETIN; HEMOGLOBIN BETA CHAIN; METHYLCELLULOSE; PROTEIN; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR SOX17; UNCLASSIFIED DRUG; HIGH MOBILITY GROUP B PROTEIN; SOX17 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL RENEWAL; CELL TRANSPLANTATION; COCULTURE; COLONY FORMING UNIT; COLONY FORMING UNIT GM; CONTROLLED STUDY; DOWN REGULATION; ERYTHROID CELL; ERYTHROPOIESIS; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GRANULOCYTE; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MACROPHAGE; MEGAKARYOCYTE ERYTHROID PROGENITOR; MEGAKARYOPOIESIS; MONOCYTE; MOUSE; MYELOID PROGENITOR CELL; MYELOPOIESIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL; THROMBOCYTE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; HEMATOPOIETIC STEM CELLS; HMGB PROTEINS; MEGAKARYOCYTE-ERYTHROID PROGENITOR CELLS; MICE; MICE, INBRED C57BL; MYELOID CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXF TRANSCRIPTION FACTORS;

EID: 85027938801     PISSN: 00121592     EISSN: 1440169X     Source Type: Journal    
DOI: 10.1111/dgd.12147     Document Type: Article

References (30)

1. Akashi, K., Traver, D., Miyamoto, T. & Weissman, I. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193-197.
2. Andrews, N., Erdjument-Bromage, H., Davidson, M., Tempst, P. & Orkin, S. H. 1993. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362, 722-728.
3. Arinobu, Y., Iwasaki, H. & Akashi, K. 2009. Origin of basophils and mast cells. Allergol. Int. 58, 21-28.
4. Boyce, J., Friend, D., Matsumoto, R., Austen, K. & Owen, W. 1995. Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. J. Exp. Med. 182, 49-57.
5. Cheng, J., Baumhueter, S., Cacalano, G., Carver-Moore, K., Thibodeaux, H., Thomas, R., Broxmeyer, H., Cooper, S., Hague, N., Moore, M. & Lasky, L. 1996. Hematopoietic defects in mice lacking the sialomucin CD34. Blood 87, 479-490.
6. Fujita, R., Takayama-Tsujimoto, M., Satoh, H., Gutiérrez, L., Aburatani, H., Fujii, S., Sarai, A., Bresnick, E. H., Yamamoto, M. & Motohashi, H. 2013. NF-E2 p45 is important for establishing normal function of platelets. Mol. Cell. Biol. 33, 2659-2670.
7. He, S., Kim, I., Lim, M. S. & Morrison, S. J. 2011. Sox17 expression confers self-renewal potential and fetal stem cell characteristics upon adult hematopoietic progenitors. Genes Dev. 25, 1613-1627.
8. Heberlein, C., Fischer, K. D., Stoffel, M., Nowock, J., Ford, A., Tessmer, U. & Stocking, C. 1992. The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: evidence for differentiation stage-specific regulation. Mol. Cell. Biol. 12, 1815-1826.
9. Ikuta, K. & Weissman, I. 1992. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl Acad. Sci. USA 89, 1502-1506.
10. Kanai-Azuma, M., Kanai, Y., Gad, J. M., Tajima, Y., Taya, C., Kurohmaru, M., Sanai, Y., Yonekawa, H., Yazaki, K., Tam, P. P. & Hayashi, Y. 2002. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129, 2367-2379.
11. Kawamoto, H., Wada, H. & Katsura, Y. 2010. A revised scheme for developmental pathways of hematopoietic cells: the myeloid-based model. Int. Immunol. 22, 65-70.
12. Kitajima, K., Tanaka, M., Zheng, J., Yen, H., Sato, A., Sugiyama, D., Umehara, H., Sakai, E. & Nakano, T. 2006. Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2. Blood 107, 1857-1863.
13. Kondo, M., Weissman, I. & Akashi, K. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661-672.
14. Lacaud, G., Carlsson, L. & Keller, G. 1998. Identification of a fetal hematopoietic precursor with B cell, T cell, and macrophage potential. Immunity 9, 827-838.
15. Ling, K., Ottersbach, K., van Hamburg, J., Oziemlak, A., Tsai, F., Orkin, S., Ploemacher, R., Hendriks, R. & Dzierzak, E. 2004. GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells. J. Exp. Med. 200, 871-882.
16. Morrison, S. J., Wandycz, A. M., Hemmati, H. D., Wright, D. E. & Weissman, I. L. 1997. Identification of a lineage of multipotent hematopoietic progenitors. Development 124, 1929-1939.
17. Nadin, B., Goodell, M. & Hirschi, K. 2003. Phenotype and hematopoietic potential of side population cells throughout embryonic development. Blood 102, 2436-2443.
18. Nakajima-Takagi, Y., Osawa, M., Oshima, M., Takagi, H., Miyagi, S., Endoh, M., Endo, T., Takayama, N., Eto, K., Toyoda, T., Koseki, H., Nakauchi, H. & Iwama, A. 2013. Role of SOX17 in hematopoietic development from human embryonic stem cells. Blood 121, 447-458.
19. Ninos, J., Jefferies, L., Cogle, C. & Kerr, W. 2006. The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells. J. Transl. Med. 4, 9.
20. Nobuhisa, I., Kato, R., Inoue, H., Takizawa, M., Okita, K., Yoshimura, A. & Taga, T. 2004. Spred-2 suppresses aorta-gonad-mesonephros hematopoiesis by inhibiting MAP kinase activation. J. Exp. Med. 199, 737-742.
21. Nobuhisa, I., Yamasaki, S., Ramadan, A. & Taga, T. 2012. CD45(low)c-Kit(high) cells have hematopoietic properties in the mouse aorta-gonad-mesonephros region. Exp. Cell Res. 318, 705-715.
22. Nobuhisa, I., Mitsujiro, O., Uemura, M., Kishikawa, Y., Anani, M., Harada, K., Takagi, H., Saito, K., Kanai-Azuma, M., Kanai, Y., Iwama, A. & Taga, T. 2014. Sox17-mediated maintenance of fetal intra-aortic hematopoietic cell clusters. Mol. Cell. Biol. 34, 1976-1990.
23. Ravetch, J. & Bolland, S. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19, 275-290.
24. Serrano, A., Gandillet, A., Pearson, S., Lacaud, G. & Kouskoff, V. 2010. Contrasting effects of Sox17- and Sox18-sustained expression at the onset of blood specification. Blood 115, 3895-3898.
25. Terstappen, L., Huang, S., Safford, M., Lansdorp, P. & Loken, M. 1991. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 77, 1218-1227.
26. Tewari, R., Gillemans, N., Harper, A., Wijgerde, M., Zafarana, G., Drabek, D., Grosveld, F. & Philipsen, S. 1996. The human beta-globin locus control region confers an early embryonic erythroid-specific expression pattern to a basic promoter driving the bacterial lacZ gene. Development 122, 3991-3999.
27. Uemura, M., Ozawa, A., Nagata, T., Kurasawa, K., Tsunekawa, N., Nobuhisa, I., Taga, T., Hara, K., Kudo, A., Kawakami, H., Saijoh, Y., Kurohmaru, M., Kanai-Azuma, M. & Kanai, Y. 2013. Sox17 haploinsufficiency results in perinatal biliary atresia and hepatitis in C57BL/6 background mice. Development 140, 639-648.
28. Weissman, I. 2000. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287, 1442-1446.
29. Yang, H., Lee, S., Kim, K., Yang, Y., Kim, J. H., Adams, R. H., Wells, J. M., Morrison, S. J., Koh, G. Y. & Kim, I. 2013. Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice. J. Clin. Invest. 123, 418-431.
30. Zhang, W., Glockner, S. C., Guo, M., Machida, E. O., Wang, D. H., Easwaran, H., Van Neste, L., Herman, J. G., Schuebel, K. E., Watkins, D. N., Ahuja, N. & Baylin, S. B. 2008. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res. 68, 2764-2772.